Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Stapler showdown: which device is safer for sleeve gastrectomy?

NCT ID NCT02731079

First seen Jan 12, 2026 · Last updated Jun 22, 2026 · Updated 18 times

Summary

This study compared two brands of surgical staplers (Covidien and Ethicon) used in sleeve gastrectomy for people with severe obesity. Researchers wanted to see if one device caused fewer complications like bleeding or leaks. The trial was terminated early and enrolled 62 adults, so the findings are limited.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MORBID OBESITY are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • William Beaumont Army Medical Center

    El Paso, Texas, 79934, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

sleeve gastrectomy with either Covidien or Ethicon powered stapler

What this could lead to

If one stapler proves better, it could guide surgeons to choose the best device for safer weight-loss surgery.

What could go wrong

The study was terminated early with only 62 participants, so results may not be reliable or apply to all patients.

Conditions

The condition(s) this trial relates to.

morbid obesity

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.